Barbara Krebs-Pohl
Listed on 4 Form D filings across 1+ issuer
· Director
Associated issuers
- CASI Pharmaceuticals, Inc. CIK 1962738 · F4
Filings (4)
-
CASI Pharmaceuticals, Inc.D · Apr 28, 2026 · F4 · Pharmaceuticals$5MView filing →
-
CASI Pharmaceuticals, Inc.D · Feb 26, 2026 · F4 · Pharmaceuticals$5MView filing →
-
CASI Pharmaceuticals, Inc.D · Jan 28, 2026 · F4 · Pharmaceuticals$5MView filing →
-
CASI Pharmaceuticals, Inc.D · Jan 28, 2026 · F4 · Pharmaceuticals$5MView filing →